Quarterly Institutional Activity in GENE

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding GENE

View all

Latest Institutional Activity in GENE

Top Purchases

Q3 2023
Two Sigma Securities, LLC Shares Held: 15.8K ($12.2K)
Q3 2023
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q2 2023
Rhumbline Advisers Shares Held: 18.7K ($14.4K)
Q2 2023
Virtu Financial LLC Shares Held: 18.2K ($14K)
Q2 2023
Gradient Investments LLC Shares Held: 2.19K ($1.69K)

Top Sells

Q4 2023
Davis Capital Management Shares Held: 0 ($0)
Q3 2023
Scarborough Advisors, LLC Shares Held: 10.6K ($8.19K)
Q3 2023
Morgan Stanley Shares Held: 87.7K ($67.5K)
Q2 2023
Ubs Group Ag Shares Held: 100 ($77)
Q1 2023
Old Mission Capital LLC Shares Held: 21.6K ($16.6K)

About GENE

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.


Insider Transactions at GENE

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on GENE

Follow GENETIC TECHNOLOGIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GENE shares.

Notify only if

Insider Trading

Get notified when an Genetic Technologies LTD insider buys or sells GENE shares.

Notify only if

News

Receive news related to GENETIC TECHNOLOGIES LTD

Track Activities on GENE